primalan® 1.25mg/2.5ml syrup
city medical store - sole proprietorship l.l.c france - 60ml glass bottle - syrup - 1.25mg/2.5ml - respiratory system-antihistamines, hyposensitisation , allergic e
primalan®
60ml glass bottle -
primobolan tablets 5mg (プリモボラン錠5mg)
bayer yakuhin, ltd. - metenolone acetate - white tablet, diameter: 7.0 mm, thickness: 2.7 mm
ciprofloxacin injection solution concentrate
pfizer labs, division of pfizer inc - ciprofloxacin (unii: 5e8k9i0o4u) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 10 mg in 1 ml
vitahealth primolin gold vegicaps soft capsule
vitahealth laboratories australia pty ltd - evening primrose oil -
vitahealth primolin 600 softgel
hovid berhad - evening primrose oil -
vitalife primolin gold epo 1000mg softgel
vitahealth malaysia sdn. bhd. - evening primrose oil -
vitahealth primolin vitagla licaps
unison nutraceuticals sdn. bhd. - borago officinalis (borage oil) -
ciprofloxacin- ciprofloxacin tablet, film coated
hikma pharmaceutical - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli , klebsiella pneumoniae , enterobacter cloacae , serratia marcescens , proteus mirabilis , providencia rettgeri , morganella morganii , citrobacter koseri (diversus) , citrobacter freundii , pseudomonas aeruginosa , methicillin-susceptible staphylococcus epidermidis , staphylococcus saprophyticus , or vancomycin-susceptible enterococcus faecalis . acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, h
ciprofloxacin- ciprofloxacin tablet, film coated
west-ward pharmaceutical corp - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. adult patients urinary tract infections caused by escherichia coli , klebsiella pneumoniae , enterobacter cloacae , serratia marcescens , proteus mirabilis , providencia rettgeri , morganella morganii , citrobacter diversus , citrobacter freundii , pseudomonas aeruginosa , methicillin-susceptible staphylococcus epidermidis , staphylococcus saprophyticus , or enterococcus faecalis . acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parain